Organization

University of California, San Diego Medical Center

6 abstracts

Abstract
Rates of pathologic complete response (pCR) after datopotamab deruxtecan (Dato) plus durvalumab (Durva) in the neoadjuvant setting: Results from the I-SPY2.2 trial.
Org: University of California, San Diego Medical Center, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, Winship Cancer Institute of Emory University,
Abstract
Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.
Org: Duke Cancer Institute, University of California, San Francisco, University of Utah, University of California, Davis Comprehensive Cancer Center, University of Chicago Medicine,
Abstract
Incidence and time to onset of immunotherapy-related adrenal insufficiency in the I-SPY2 trial.
Org: University of Chicago Medicine, University of Chicago, University of California, San Francisco Department of Medicine, University of California, San Francisco Department of Surgery, University of California, San Francisco,
Abstract
Implementation of standardized electronic documentation of goals of care discussions to improve cancer care.
Org: University of California, San Diego Medical Center, Moores Cancer Center at UC San Diego Health, Cleveland Clinic Lerner College of Medicine, Endocrinology and Metabolism Institute, Doris A. Howell Palliative Care Service,
Abstract
Multi-institutional study of reirradiation for recurrent high grade glioma.
Org: Alexander T. Augusta Military Medical Center, Wake Forest Baptist Health, Wake Forest School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Department of Radiation Oncology, Washington University School of Medicine in St. Louis,
Abstract
Clinical features and outcomes of patients with breast cancer with leptomeningeal carcinomatosis.
Org: University of California, San Diego Medical Center, UC San Diego Moores Cancer Center, University of California, San Diego Center for Advanced Laboratory Medicine,